BriaCell Therapeutics BCTX
NASDAQ BCTX
$4.08 -0.08 (-1.81%)
At close: Sep 29, 2026 · 4:00 PM EDT

BriaCell Therapeutics (BCTX) Total Non-Current Liabilities (2020 - 2026)

Updated

BriaCell Therapeutics' Total Non-Current Liabilities came in at $71,854 for fiscal Q3 2026 (quarter ended Apr 30, 2026), down 90.2% from $730,012 a year earlier and down 63.2% from the prior quarter.

Analysis

BriaCell Therapeutics (BCTX) Total Non-Current Liabilities (2020 - 2026) Analysis & Trends

At the end of FY2025 (ended Jul 31, 2025), BriaCell Therapeutics' Total Non-Current Liabilities was $337,672, down 69.2% from FY2024.

  • Total Non-Current Liabilities has declined in each of the last three fiscal years, though with a five-year compound annual growth rate of 16.7% (FY2020 to FY2025).
  • Going back by fiscal year, Total Non-Current Liabilities was $1.1 million in FY2024 (-96.2%), $29.14 million in FY2023 (-6.9%), $31.31 million in FY2022 (+5.0%) and $29.82 million in FY2021.
  • The fiscal Q3 2026 figure represents the lowest quarterly Total Non-Current Liabilities in data going back to fiscal Q4 2020.
  • Year-over-year, Total Non-Current Liabilities has declined for 12 consecutive quarters, with an average decline of 85.1% over the last eight quarters.
  • The fastest year-over-year change in Total Non-Current Liabilities over five years came in fiscal Q4 2022 (growth of 5.0%), and the weakest in fiscal Q4 2024 (a decline of 96.2%).
  • Business Quant data shows BCTX's Total Non-Current Liabilities at $195,096 (Q2 2026), $406,873 (Q1 2026) and $337,672 (Q4 2025) in the three fiscal quarters before Q3 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 105.99 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 106.45 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 80.25 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 48.34 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -967.00 Mn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 81.11 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 36.04 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 100.86 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 5.92 Bn
10 BriaCell Therapeutics 30.16 Mn 29.51 Mn - 71,854.00
Historic Data

Historic Data

Download Data
DateValue
Apr 30, 2026 71,854.00
Jan 31, 2026 195,096.00
Oct 31, 2025 406,873.00
Jul 31, 2025 337,672.00
Apr 30, 2025 730,012.00
Jan 31, 2025 905,838.00
Oct 31, 2024 1.71 Mn
Jul 31, 2024 1.10 Mn
Apr 30, 2024 5.68 Mn
Jan 31, 2024 16.62 Mn
Oct 31, 2023 15.06 Mn
Jul 31, 2023 29.14 Mn
Apr 30, 2023 34.23 Mn
Jan 31, 2023 34.77 Mn
Oct 31, 2022 27.14 Mn
Jul 31, 2022 31.31 Mn
Apr 30, 2022 278,396.00
Jan 31, 2022 248,486.00
Jul 31, 2021 29.82 Mn
Jul 31, 2020 140,104.95
API Access

BriaCell Therapeutics Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=BCTX&period=max&api_key=YOUR_API_KEY